GAP-1 serum
GAP1, or Global Action Plan 1, is a global program which aims to optimalize yields by bringing together the best from biobanks and registers world-wide. At the same time, across-the-border collaborations between researchers will ensure a great collective competence.
Members of the GAP1-Serum project: William Watson (Dublin), Lorelei Mucci (Boston), Kenneth Evans (Toronto), Kristin Austlid Taskén (Oslo), GAP1-Unique TMA (Oslo University Hospital (Viktor Berge (PI), Olov Øgren (project coordinator), Johns Hopkins School of Medicine, University of Washington, Helsinki University Central Hospital, Emory University, Université de Montréal, University of Montreal Hospital Research Center, The University of Mississippi Medical Center, Jonsson Comprehensive Cancer Center, Cedars-Sinai Medical Center, Duke University).